TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy

Archive ouverte

Spitali, Pietro | Zaharieva, Irina | Bohringer, Stefan | Hiller, Monika | Chaouch, Amina | Roos, Andreas | Scotton, Chiara | Claustres, Mireille | Bello, Luca | Mcdonald, Craig, M | Hoffman, Eric, P | Koeks, Zaida | Suchiman, H Eka | Cirak, Sebahattin | Scoto, Mariacristina | Reza, Mojgan | ‘t Hoen, Peter | Niks, Erik, H | Tuffery-Giraud, Sylvie | Lochmuller, Hanns | Ferlini, Alessandra | Muntoni, Francesco | Aartsma-Rus, Annemieke

Edité par CCSD ; Nature Publishing Group -

International audience. Duchenne muscular dystrophy (DMD) is caused by pathogenic variants in the DMD gene leading to the lack of dystrophin. Variability in the disease course suggests that other factors influence disease progression. With this study we aimed to identify genetic factors that may account for some of the variability in the clinical presentation. We compared whole-exome sequencing (WES) data in 27 DMD patients with extreme phenotypes to identify candidate variants that could affect disease progression. Validation of the candidate SNPs was performed in two independent cohorts including 301 (BIO-NMD cohort) and 109 (CINRG cohort of European ancestry) DMD patients, respectively. Variants in the Tctex1 domain containing 1 (TCTEX1D1) gene on chromosome 1 were associated with age of ambulation loss. The minor alleles of two independent variants, known to affect TCTEX1D1 coding sequence and induce skipping of its exon 4, were associated with earlier loss of ambulation. Our data show that disease progression of DMD is affected by a new locus on chromosome 1 and demonstrate the possibility to identify genetic modifiers in rare diseases by studying WES data in patients with extreme phenotypes followed by multiple layers of validation

Suggestions

Du même auteur

Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants

Archive ouverte | van den Bergen, Janneke | CCSD

International audience. OBJECTIVE:Duchenne muscular dystrophy (DMD) is characterised by progressive muscle weakness. It has recently been reported that single nucleotide polymorphisms (SNPs) located in the SPP1 and ...

Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy

Archive ouverte | Bello, Luca | CCSD

International audience. The expressivity of Mendelian diseases can be influenced by factors independent from the pathogenic mutation: in Duchenne muscular dystrophy (DMD), for instance, age at loss of ambulation (Lo...

A multicenter comparison of quantification methods for antisense oligonucleotideinduced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures

Archive ouverte | Hiller, Monika | CCSD

International audience. Background Duchenne muscular dystrophy is a lethal disease caused by lack of dystrophin. Skipping of exons adjacent to out-of-frame deletions has proven to restore dystrophin expression in Du...

Chargement des enrichissements...